23andMe Investor Presentation Deck

Consumer 12.2M Genotyped Customers¹ »»>> Consumer Powered Healthcare Flywheel We run hundreds of billions of association tests per year that further our unique understanding of human biology Data 80% Opt-In to Research Research olli XX Phenotypic Data Genetic Data Insights 1. As of December 31, 2021. 2. As of March 31, 2021. Programs include collaborated, 100% owned and royalty interest targets. 4B+ Phenotypic Data Points¹ Innovative Results Return Value to the Customer Therapeutics / Product Drug Discoveries 40+ Programs² Copyright © 2022 23and Me, Inc. Novel Consumer Products ✔ 23andMe 12

View entire presentation